These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 11528420)
1. Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A. Zheng F; Erreger K; Low CM; Banke T; Lee CJ; Conn PJ; Traynelis SF Nat Neurosci; 2001 Sep; 4(9):894-901. PubMed ID: 11528420 [TBL] [Abstract][Full Text] [Related]
2. Allosteric interaction between zinc and glutamate binding domains on NR2A causes desensitization of NMDA receptors. Erreger K; Traynelis SF J Physiol; 2005 Dec; 569(Pt 2):381-93. PubMed ID: 16166158 [TBL] [Abstract][Full Text] [Related]
3. The function of the amino terminal domain in NMDA receptor modulation. Huggins DJ; Grant GH J Mol Graph Model; 2005 Jan; 23(4):381-8. PubMed ID: 15670959 [TBL] [Abstract][Full Text] [Related]
5. Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors. Kloda A; Clements JD; Lewis RJ; Adams DJ Mol Pharmacol; 2004 Jun; 65(6):1386-96. PubMed ID: 15155832 [TBL] [Abstract][Full Text] [Related]
6. Zinc and ifenprodil allosterically inhibit two separate polyamine-sensitive sites at N-methyl-D-aspartate receptor complex. Berger ML; Rebernik P J Pharmacol Exp Ther; 1999 Jun; 289(3):1584-91. PubMed ID: 10336556 [TBL] [Abstract][Full Text] [Related]
7. Use of trifluoroperazine isolates a [(3)H]Ifenprodil binding site in rat brain membranes with the pharmacology of the voltage-independent ifenprodil site on N-methyl-D-aspartate receptors containing NR2B subunits. Coughenour LL; Barr BM J Pharmacol Exp Ther; 2001 Jan; 296(1):150-9. PubMed ID: 11123375 [TBL] [Abstract][Full Text] [Related]
8. Deletion of the C-terminal domain of the NR2B subunit alters channel properties and synaptic targeting of N-methyl-D-aspartate receptors in nascent neocortical synapses. Mohrmann R; Köhr G; Hatt H; Sprengel R; Gottmann K J Neurosci Res; 2002 May; 68(3):265-75. PubMed ID: 12111856 [TBL] [Abstract][Full Text] [Related]
9. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission. Frizelle PA; Chen PE; Wyllie DJ Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008 [TBL] [Abstract][Full Text] [Related]
10. The NR1 M3 domain mediates allosteric coupling in the N-methyl-D-aspartate receptor. Blanke ML; VanDongen AM Mol Pharmacol; 2008 Aug; 74(2):454-65. PubMed ID: 18483226 [TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of glycine-independent desensitization of NR1/NR2A receptors. Hu B; Zheng F J Pharmacol Exp Ther; 2005 May; 313(2):563-9. PubMed ID: 15650113 [TBL] [Abstract][Full Text] [Related]
12. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling. Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381 [TBL] [Abstract][Full Text] [Related]
13. Protein kinase C enhances glycine-insensitive desensitization of NMDA receptors independently of previously identified protein kinase C sites. Jackson MF; Konarski JZ; Weerapura M; Czerwinski W; MacDonald JF J Neurochem; 2006 Mar; 96(6):1509-18. PubMed ID: 16417568 [TBL] [Abstract][Full Text] [Related]
14. Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding. Marinelli L; Cosconati S; Steinbrecher T; Limongelli V; Bertamino A; Novellino E; Case DA ChemMedChem; 2007 Oct; 2(10):1498-510. PubMed ID: 17849398 [TBL] [Abstract][Full Text] [Related]
15. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands. Moretti L; Pentikäinen OT; Settimo L; Johnson MS J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371 [TBL] [Abstract][Full Text] [Related]
16. Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists. Hoare SR; Sullivan SK; Schwarz DA; Ling N; Vale WW; Crowe PD; Grigoriadis DE Biochemistry; 2004 Apr; 43(13):3996-4011. PubMed ID: 15049707 [TBL] [Abstract][Full Text] [Related]
17. Tonic facilitation of glutamate release by glycine binding sites on presynaptic NR2B-containing NMDA autoreceptors in the rat visual cortex. Li YH; Han TZ; Meng K Neurosci Lett; 2008 Feb; 432(3):212-6. PubMed ID: 18248890 [TBL] [Abstract][Full Text] [Related]
18. Excitatory amino acid receptors of the electrosensory system: the NR1/NR2B N-methyl-D-aspartate receptor. Harvey-Girard E; Dunn RJ J Neurophysiol; 2003 Feb; 89(2):822-32. PubMed ID: 12574460 [TBL] [Abstract][Full Text] [Related]
19. Differential effects on current kinetics by point mutations in the lurcher motif of NR1/NR2A receptors. Hu B; Zheng F J Pharmacol Exp Ther; 2005 Mar; 312(3):899-904. PubMed ID: 15501991 [TBL] [Abstract][Full Text] [Related]
20. Subunit arrangement and function in NMDA receptors. Furukawa H; Singh SK; Mancusso R; Gouaux E Nature; 2005 Nov; 438(7065):185-92. PubMed ID: 16281028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]